These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 32564866

  • 1. Glucocorticoid metabolism and the action of 11 beta-hydroxysteroid dehydrogenase 2 in canine congestive heart failure.
    Bode EF, Markby GR, Boag AM, Martinez-Pereira Y, Corcoran BM, Farquharson C, Sooy K, Homer NZM, Jamieson PM, Culshaw GJ.
    Vet J; 2020 Apr; 258():105456. PubMed ID: 32564866
    [Abstract] [Full Text] [Related]

  • 2. Cortisol urinary metabolites in dogs with hypercortisolism, congestive heart failure, and healthy dogs: pilot investigation.
    Quilez E, Burchell RK, Thorstensen EB, Weidgraaf K, Parbhu SE, Lopez-Villalobos N, Gal A.
    J Vet Diagn Invest; 2020 Mar; 32(2):317-323. PubMed ID: 31924129
    [Abstract] [Full Text] [Related]

  • 3. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?
    Palermo M, Delitala G, Sorba G, Cossu M, Satta R, Tedde R, Pala A, Shackleton CH.
    J Endocrinol Invest; 2000 Mar; 23(7):457-62. PubMed ID: 11005270
    [Abstract] [Full Text] [Related]

  • 4. A simple LC-MS/MS method for the determination of cortisol, cortisone and tetrahydro-metabolites in human urine: assay development, validation and application in depression patients.
    Zhai X, Chen F, Zhu C, Lu Y.
    J Pharm Biomed Anal; 2015 Mar 25; 107():450-5. PubMed ID: 25668797
    [Abstract] [Full Text] [Related]

  • 5. Glucocorticoid metabolism in critically ill dogs (Canis lupus familiaris).
    Boag AM, Brown A, Koenigshof A, Homer N, Sooy K, Jamieson PM.
    Domest Anim Endocrinol; 2020 Jul 25; 72():106437. PubMed ID: 32169755
    [Abstract] [Full Text] [Related]

  • 6. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
    Tsilchorozidou T, Honour JW, Conway GS.
    J Clin Endocrinol Metab; 2003 Dec 25; 88(12):5907-13. PubMed ID: 14671189
    [Abstract] [Full Text] [Related]

  • 7. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity.
    Gelding SV, Taylor NF, Wood PJ, Noonan K, Weaver JU, Wood DF, Monson JP.
    Clin Endocrinol (Oxf); 1998 Feb 25; 48(2):153-62. PubMed ID: 9579226
    [Abstract] [Full Text] [Related]

  • 8. Role of 11βHSD type 2 enzyme activity in essential hypertension and children with chronic kidney disease (CKD).
    Mongia A, Vecker R, George M, Pandey A, Tawadrous H, Schoeneman M, Muneyyirci-Delale O, Nacharaju V, Ten S, Bhangoo A.
    J Clin Endocrinol Metab; 2012 Oct 25; 97(10):3622-9. PubMed ID: 22872687
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone replacement inhibits renal and hepatic 11 beta-hydroxysteroid dehydrogenases in ACTH-deficient patients.
    Walker BR, Andrew R, MacLeod KM, Padfield PL.
    Clin Endocrinol (Oxf); 1998 Aug 25; 49(2):257-63. PubMed ID: 9828916
    [Abstract] [Full Text] [Related]

  • 10. Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function.
    Quinkler M, Zehnder D, Lepenies J, Petrelli MD, Moore JS, Hughes SV, Cockwell P, Hewison M, Stewart PM.
    Eur J Endocrinol; 2005 Aug 25; 153(2):291-9. PubMed ID: 16061836
    [Abstract] [Full Text] [Related]

  • 11. Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.
    Stewart PM, Boulton A, Kumar S, Clark PM, Shackleton CH.
    J Clin Endocrinol Metab; 1999 Mar 25; 84(3):1022-7. PubMed ID: 10084590
    [Abstract] [Full Text] [Related]

  • 12. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man.
    Palermo M, Shackleton CH, Mantero F, Stewart PM.
    Clin Endocrinol (Oxf); 1996 Nov 25; 45(5):605-11. PubMed ID: 8977758
    [Abstract] [Full Text] [Related]

  • 13. Increased cortisol metabolites and reduced activity of 11beta-hydroxysteroid dehydrogenase in patients on hemodialysis.
    N'Gankam V, Uehlinger D, Dick B, Frey BM, Frey FJ.
    Kidney Int; 2002 May 25; 61(5):1859-66. PubMed ID: 11967038
    [Abstract] [Full Text] [Related]

  • 14. Cortisol metabolism after weight loss: associations with 11 β-HSD type 1 and markers of obesity in women.
    Rask E, Simonyte K, Lönn L, Axelson M.
    Clin Endocrinol (Oxf); 2013 May 25; 78(5):700-5. PubMed ID: 22233384
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11 beta-hydroxysteroid dehydrogenase in vivo.
    Best R, Walker BR.
    Clin Endocrinol (Oxf); 1997 Aug 25; 47(2):231-6. PubMed ID: 9302399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.